Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You are browsing as a GUEST
Title of the item:

Carboplatin/etoposide: Veno-occlusive disease and metastatic haemorrhage: 2 case reports.

Title :
Carboplatin/etoposide: Veno-occlusive disease and metastatic haemorrhage: 2 case reports.
Subject Terms :
CARBOPLATIN
ETOPOSIDE
METASTASIS
HEMORRHAGE
NEOADJUVANT chemotherapy
Source :
Reactions Weekly; 3/27/2021, Vol. 1848 Issue 1, p102-102, 1p
Periodical
Subsequently, the children died due to treatment-related toxicities, including veno-occlusive disease (n=1) or metastatic haemorrhage (n=1) [ I time to reactions onset not stated i ]. B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event In a retrospective study including 92 children, conducted between 2002 and 2015, two children [ I sexes and exact ages not stated i ] were described, who developed veno-occlusive disease (n=1) or metastatic haemorrhage (n=1) during treatment with carboplatin and etoposide for metastatic medulloblastoma. [Extracted from the article]
Copyright of Reactions Weekly is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.